Rita Conde-Saude
Brussels, BRU 1070, Belgium
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications
FAP-Targeted Radionuclide Therapy: Mechanisms, Clinical Applications, and Combination Strategies.
Journal: Biomedicines
Published: May 23, 2026
Development and Validation of an 18F-Fluorodeoxyglucose Positron Emission Tomography-Computed Tomography-Based Imaging Score to Predict 12-Week Life Expectancy in Advanced Chemorefractory Colorectal Cancer.
Journal: JCO clinical cancer informatics
Published: April 30, 2025
Immunotherapy for advanced and recurrent malignant pleural mesothelioma.
Journal: The Cochrane database of systematic reviews
Published: September 18, 2024
Efficacy and safety of short-course radiotherapy versus total neoadjuvant therapy in older rectal cancer patients: a randomised pragmatic trial (SHAPERS).
Journal: ESMO gastrointestinal oncology
Published: June 05, 2024
Total Neoadjuvant Therapy in Localized Pancreatic Cancer: Is More Better?
Journal: Cancers
Published: May 15, 2024
Cancer-Associated Fibroblasts in Pancreatic Ductal Adenocarcinoma or a Metaphor for Heterogeneity: From Single-Cell Analysis to Whole-Body Imaging.
Journal: Biomedicines
Published: January 30, 2024
Prognostic Value of Circulating Cytokines in Chemorefractory Colorectal Cancer.
Journal: Cancers
Published: October 30, 2023
Immunotherapies in non-metastatic gastrointestinal cancers.
Journal: Current opinion in oncology
Published: May 24, 2023
Preexisting evidence and outcome of phase III trials in gastrointestinal oncology: a systematic review.
Journal: Journal of the National Cancer Institute
Published: October 27, 2022
Regorafenib in combination with immune checkpoint inhibitors for mismatch repair proficient (pMMR)/microsatellite stable (MSS) colorectal cancer.
Journal: Cancer treatment reviews
Published: July 25, 2022
The emerging role of immunotherapy in the treatment of anal cancer.
Journal: Current opinion in pharmacology
Published: July 22, 2022
Mind the target: human epidermal growth factor receptor 2 in colorectal cancer.
Journal: Current opinion in oncology
Published: June 22, 2022
Last Updated: 09/26/2026